EFFICACY AND SAFETY OF VIDOFLUDIMUS CALCIUM (IMU-838) IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (UC): RESULTS FROM THE PROSPECTIVE PLACEBO-CONTROLLED PHASE 2 CALDOSE-1 TRIAL

Geert R. D'Haens  ¹     Sowmya Rajendra  ²     Daniel Vitt  ³     Hella Kohlhof  ⁴     Andreas Muehler  ^5    
1 AMC Amsterdam Inflammatory Bowel Disease Centre - Academic Medical Center, AMC Amsterdam Inflammator, Amsterdam, Netherlands
² Immunic, Inc, New York, United States
³ Immunic AG, Planegg / Martinsried, Germany
⁴ Immunic AG, Planegg-Martinsried, Germany
⁵ Immunic AG, Martinsried, Germany

Topic
Endoscopy, Histopathology, IBD

Session
The new kids on the block in IBD: Part 2

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)